Skip to main content
SEP ANALYTICAL (SHANGHAI) CO., LTD. logo

SEP ANALYTICAL (SHANGHAI) CO., LTD. — Investor Relations & Filings

Ticker · 301228 ISIN · CNE1000057C6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 609 across all filing types
Latest filing 2022-01-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301228

About SEP ANALYTICAL (SHANGHAI) CO., LTD.

https://www.sepchina.cn

SEP Analytical (Shanghai) Co., Ltd. specializes in the provision of high-performance chromatography consumables and analytical laboratory equipment. The company’s core portfolio includes high-performance liquid chromatography (HPLC) columns, gas chromatography (GC) columns, and solid-phase extraction (SPE) products. It also supplies a wide range of laboratory essentials such as vials, caps, and syringe filters. These products are engineered to support precise chemical analysis across various sectors, including pharmaceutical research, environmental testing, and food safety. The company focuses on delivering reliable separation solutions that enhance the sensitivity and reproducibility of analytical workflows. Through continuous technical innovation, SEP Analytical provides specialized tools designed to meet the rigorous demands of modern laboratory environments and complex sample matrices.

Recent filings

Filing Released Lang Actions
海通证券股份有限公司关于公司首次公开发行股票并在创业板上市之上市保荐书
Regulatory Filings Classification · 95% confidence The document is a detailed listing related to a company's initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It includes extensive information about the company, its core technologies, R&D projects, patents, honors, and financial data. The document is titled as a "上市保荐书" which translates to "Listing Sponsorship Letter" or "Sponsorship Document" for IPO. It references regulatory laws and securities regulations, indicating it is a formal filing related to the IPO process. This type of document is neither an annual report, earnings release, nor a simple announcement. It is a comprehensive regulatory filing related to the IPO and listing process, which does not fit into categories like Annual Report (10-K), Earnings Release (ER), or Management Reports (MDA). It is not a proxy statement, voting results, or board change announcement. Given the nature and content, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2022-01-26 Chinese
首次公开发行股票并在创业板上市之上市公告书
Regulatory Filings Classification · 95% confidence The document is titled as a "上市公告书" which translates to "Listing Announcement" or "IPO Listing Announcement". It details the company's initial public offering (IPO) and listing on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). The text includes extensive information about the stock issuance, listing date, share distribution, lock-up periods, risk factors related to the IPO, regulatory approvals from the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange, and company background. It is not a financial report like an annual or quarterly report, nor is it a simple announcement of a report publication. Instead, it is a formal announcement document related to the company's IPO and stock listing. This type of document fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement about the company's stock listing and IPO details, not a financial report or other specific filing type.
2022-01-26 Chinese
国浩律师（杭州）事务所关于公司首次公开发行的股票在深圳证券交易所创业板上市之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the initial public offering (IPO) and listing of a company on the Shenzhen Stock Exchange's ChiNext board. It references regulatory approvals, company qualifications, and compliance with listing rules. The document is a legal opinion related to the IPO process, not a financial report, earnings release, or management discussion. It is a specialized legal document supporting the IPO listing process, which fits best under the category of Regulatory Filings (RNS) as it does not match other specific categories like Annual Report, Capital Update, or M&A filings. The document length is about 5,010 characters, which is substantial but it is not a financial report itself. Therefore, the best classification is Regulatory Filings (RNS).
2022-01-26 Chinese
首次公开发行股票并在创业板上市发行结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "首次公开发行股票并在创业板上市发行结果公告" which translates to "Initial Public Offering (IPO) and Listing Results Announcement on the ChiNext Board." It details the issuance results of shares, including the number of shares issued, pricing, subscription statistics, strategic placement, and underwriting details. The document is an announcement of the results of a capital raising event (IPO) and listing, not a full financial report or prospectus. It is relatively short (3458 characters) and focuses on the issuance and subscription results rather than financial statements or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2022-01-24 Chinese
首次公开发行股票并在创业板上市招股说明书
Regulatory Filings
2022-01-24 Chinese
首次公开发行股票并在创业板上市网下发行初步配售结果公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial offline allotment results for a company's initial public offering (IPO) and listing on the ChiNext board. It includes information about the strategic placement, offline and online issuance, subscription details, payment instructions, and allotment results. The document references regulatory approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and it provides detailed allocation tables and investor information. This type of document is a formal announcement of the allotment results following an IPO issuance, which fits the category of Capital/Financing Update (CAP) as it relates to fundraising and issuance of new shares. It is not a full financial report, earnings release, or regulatory filing, but a specific update on the capital raising process and share allocation.
2022-01-20 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.